| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 81479 |
Unlisted molecular pathology procedure |
1,021 |
630 |
$2.38M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
30,824 |
28,643 |
$1.11M |
| 81415 |
|
323 |
293 |
$928K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
27,885 |
26,718 |
$785K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
25,902 |
24,573 |
$631K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
33,002 |
31,641 |
$433K |
| 81229 |
|
576 |
505 |
$387K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
10,815 |
10,131 |
$323K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
10,660 |
10,044 |
$322K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,127 |
2,879 |
$241K |
| 88271 |
|
2,535 |
2,267 |
$222K |
| 88341 |
|
2,293 |
1,987 |
$190K |
| 88342 |
|
4,171 |
3,790 |
$184K |
| 88237 |
|
2,109 |
1,987 |
$176K |
| 88112 |
|
2,192 |
2,059 |
$149K |
| 88264 |
|
1,809 |
1,721 |
$148K |
| 87481 |
|
3,155 |
1,473 |
$121K |
| 86832 |
|
1,191 |
1,032 |
$120K |
| 86833 |
|
1,163 |
1,011 |
$108K |
| 88275 |
|
2,075 |
1,942 |
$96K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,552 |
1,464 |
$95K |
| 87480 |
|
5,931 |
5,249 |
$90K |
| 87660 |
|
5,763 |
5,119 |
$90K |
| 87510 |
|
5,698 |
5,077 |
$90K |
| 88141 |
|
13,500 |
12,886 |
$89K |
| 88312 |
|
3,539 |
3,296 |
$85K |
| 82652 |
|
2,496 |
2,314 |
$81K |
| 88262 |
|
690 |
656 |
$76K |
| 88360 |
|
1,518 |
1,362 |
$62K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
1,030 |
360 |
$62K |
| 87625 |
|
2,121 |
2,028 |
$59K |
| 88142 |
|
4,386 |
4,198 |
$57K |
| 87150 |
|
1,774 |
1,611 |
$49K |
| 81406 |
|
201 |
179 |
$49K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,589 |
1,491 |
$48K |
| 88230 |
|
476 |
441 |
$47K |
| 88304 |
|
2,589 |
2,406 |
$43K |
| 88291 |
|
4,035 |
3,695 |
$26K |
| 81228 |
|
41 |
38 |
$23K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,035 |
356 |
$20K |
| 88350 |
|
245 |
222 |
$15K |
| 81408 |
|
12 |
12 |
$14K |
| 81405 |
|
56 |
51 |
$12K |
| 88321 |
|
1,803 |
1,649 |
$11K |
| 88173 |
|
272 |
225 |
$8K |
| G0452 |
Molecular pathology procedure; physician interpretation and report |
1,401 |
1,354 |
$8K |
| 81407 |
|
12 |
12 |
$7K |
| 88323 |
|
237 |
212 |
$6K |
| 81243 |
|
197 |
169 |
$5K |
| 88313 |
|
144 |
135 |
$5K |
| 88346 |
|
263 |
239 |
$4K |
| 89320 |
|
320 |
296 |
$3K |
| 81403 |
|
13 |
13 |
$2K |
| 87529 |
|
37 |
30 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
510 |
379 |
$117.30 |
| 80500 |
|
12 |
12 |
$106.70 |